New Investigational Stimulation Protocol for Treatment of Major Depression Disorder (MDD)
← catalyst calendarSponsored by Brainsway (industry) · BWAY — their whole pipeline →.
Phase
Not applicable
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
104actual
Sites
9
Countries
India, Israel, United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2024-04-29 | actual | When the study began enrolling |
| Primary completion | 2025-02-26 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-03-05 | actual | The whole study's end, after follow-up |
| First posted | 2024-04-10 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-03-10 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Major Depressive Disorder
Intervention
- Device: Brainsway Deep TMS System — also filed as Brainsway Deep TMS Device
Primary outcome
what the primary-completion date above is the date OFChange in Hamilton Depression Rating Scale (HDRS)-21 score in the investigational group
measured 6 weeks
Permalink · BWAY's whole pipeline · Catalyst calendar · Every registered study · What changed